The iLet bionic pancreas (BP)1 significantly increased the percentage of time adults with type 1 diabetes (T1D) had glucose levels between 70–180 mg/dl, when compared to usual care (UC) therapy...

Pancreatic beta cells that do not produce sufficient insulin in people with type 2 diabetes (T2D) are not permanently damaged during the early stages of the disease and can be restored to normal...

Continuous glucose monitoring (CGM) evaluations in islet transplant recipients who have been insulin independent for an average of 10 years show near-normal glycemic profiles and time-in-range...

One Drop, a leader in the development of digital therapeutics solutions for diabetes and other chronic conditions, today announced the expansion of their AI-powered Predictive Insights to include...

We are advised by Global Governance Advisors that journalists and other readers should disregard the news release, Global Governance Advisors Unveils IR Compensation and Responsibilities Survey...